Eli Lilly-Morphic see US antitrust waiting period expire
MLex Summary: The US antitrust waiting period of Eli Lilly's proposed acquisition of Morphic Holding has expired, according to a Morphic filing with the US Securities and Exchange Commission.Extract....To view the full article, register now.
Already a subscriber? Click here to view full article